# Study of NPF-08 in Patients Who Receive Colonoscopy

> **NCT03794310** · PHASE3 · COMPLETED · sponsor: **Nihon Pharmaceutical Co., Ltd** · enrollment: 632 (actual)

## Conditions studied

- Patients Who Receive Colonoscopy

## Interventions

- **DRUG:** NPF-08 （1-day treatment）
- **DRUG:** NPF-08 （2-day split dose）
- **DRUG:** Moviprep（1-day treatment）

## Key facts

- **NCT ID:** NCT03794310
- **Lead sponsor:** Nihon Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-05
- **Primary completion:** 2019-06-19
- **Final completion:** 2019-06-19
- **Target enrollment:** 632 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03794310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03794310, "Study of NPF-08 in Patients Who Receive Colonoscopy". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03794310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*